Cargando…

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC

BACKGROUND: Immunotherapy has been proven effective among several human cancer types, including Squamous cell lung carcinoma (SqCLC). ERAP2 plays a pivotal role in peptide trimming of many immunological processes. However, the prognostic role of ERAP2 and its relationship with immune cell infiltrati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zhenlin, Tian, He, Bie, Fenglong, Xu, Jiachen, Zhou, Zheng, Yang, Junhui, Li, Renda, Peng, Yue, Bai, Guangyu, Tian, Yanhua, Chen, Ying, Liu, Lei, Fan, Tao, Xiao, Chu, Zheng, Yujia, Zheng, Bo, Wang, Jie, Li, Chunxiang, Gao, Shugeng, He, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725995/ https://www.ncbi.nlm.nih.gov/pubmed/34992605 http://dx.doi.org/10.3389/fimmu.2021.788985

Ejemplares similares

Clinical and Pathologic Complete Response to Gefitinib in a Patient with SqCLC Harboring EGFR p.E746_S752delinsV Mutation
por: Zhuang, Weitao, et al.
Publicado: (2021)

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
por: Xiao, Chu, et al.
Publicado: (2022)

Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis
por: Tian, He, et al.
Publicado: (2023)

TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma
por: Peng, Yue, et al.
Publicado: (2022)

Multiple primary lung cancer: Updates of clinical management and genomic features
por: Tian, He, et al.
Publicado: (2023)

PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer
por: Yang, Zhenlin, et al.
Publicado: (2021)

Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma
por: Yang, Zhenlin, et al.
Publicado: (2020)

PVR/TIGIT and PD-L1/PD-1 expression predicts survival and enlightens combined immunotherapy in lung squamous cell carcinoma
por: Yang, Zhenlin, et al.
Publicado: (2022)

Utility of (18)F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer
por: Chen, Xiaowei, et al.
Publicado: (2023)

A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis
por: Fan, Tao, et al.
Publicado: (2021)

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
por: Bie, Fenglong, et al.
Publicado: (2022)

Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians
por: Bie, Fenglong, et al.
Publicado: (2021)

Polymorphisms in ERAP1 and ERAP2 Genes Are Associated With Tuberculosis in the Han Chinese
por: Zhang, Shuqiong, et al.
Publicado: (2020)

H3K36 trimethylation-mediated biological functions in cancer
por: Xiao, Chu, et al.
Publicado: (2021)

The Multifaceted Nature of Aminopeptidases ERAP1, ERAP2, and LNPEP: From Evolution to Disease
por: Paladini, Fabiana, et al.
Publicado: (2020)

The Differential Expression of ERAP1/ERAP2 and Immune Cell Activation in Pre-eclampsia
por: Seamon, Kimberly, et al.
Publicado: (2020)

Genetic association of ERAP1 and ERAP2 with eclampsia and preeclampsia in northeastern Brazilian women
por: Ferreira, Leonardo Capistrano, et al.
Publicado: (2021)

The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities
por: Martín-Esteban, Adrian, et al.
Publicado: (2022)

How ERAP1 and ERAP2 Shape the Peptidomes of Disease-Associated MHC-I Proteins
por: López de Castro, José A.
Publicado: (2018)

ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?
por: D’Amico, Silvia, et al.
Publicado: (2021)

Can ERAP1 and ERAP2 Form Functional Heterodimers? A Structural Dynamics Investigation
por: Papakyriakou, Athanasios, et al.
Publicado: (2022)

CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition
por: Fan, Tao, et al.
Publicado: (2022)

H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy
por: Xiao, Chu, et al.
Publicado: (2023)

The therapeutic significance of the novel photodynamic material TPE-IQ-2O in tumors
por: Wang, Liyu, et al.
Publicado: (2020)

ERAP1/ERAP2 and RUNX3 polymorphisms are not associated with ankylosing spondylitis susceptibility in Chinese Han
por: Su, W., et al.
Publicado: (2018)

Functionally distinct ERAP1 and ERAP2 are a hallmark of HLA-A29-(Birdshot) Uveitis
por: Kuiper, Jonas J W, et al.
Publicado: (2018)

Transmembrane Protein-Based Risk Model and H3K4me3 Modification Characteristics in Lung Adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2022)

A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients
por: Tian, Yanhua, et al.
Publicado: (2020)

Increase in Hypotonic Stress-Induced Endocytic Activity in Macrophages via ClC-3
por: Yan, Yutao, et al.
Publicado: (2014)

Chloride Channelopathies of ClC-2
por: Bi, Miao Miao, et al.
Publicado: (2013)

An Overview on ERAP Roles in Infectious Diseases
por: Saulle, Irma, et al.
Publicado: (2020)

An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes
por: Paladini, Fabiana, et al.
Publicado: (2018)

A Multi-Center Validated Subtyping Model of Esophageal Cancer Based on Three Metabolism-Related Genes
por: Liu, Yu, et al.
Publicado: (2021)

Lipid metabolism–related lncRNA SLC25A21‐AS1 promotes the progression of oesophageal squamous cell carcinoma by regulating the NPM1/c‐Myc axis and SLC25A21 expression
por: Liu, Yu, et al.
Publicado: (2022)

Research and progress on ClC-2
por: Wang, Hongwei, et al.
Publicado: (2017)

Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study
por: Zhou, Bolun, et al.
Publicado: (2022)

A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes
por: Zhou, Bolun, et al.
Publicado: (2022)

Concerted In Vitro Trimming of Viral HLA-B27-Restricted Ligands by Human ERAP1 and ERAP2 Aminopeptidases
por: Lorente, Elena, et al.
Publicado: (2013)

ERAP1-ERAP2 dimers trim MHC I-bound precursor peptides; implications for understanding peptide editing
por: Chen, Hanna, et al.
Publicado: (2016)

The emerging multifunctional roles of ERAP1, ERAP2 and IRAP between antigen processing and renin-angiotensin system modulation
por: Mattorre, Benedetta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1d5labb46b849i2ml2k9225481